These Analysts Slash Their Forecasts On ANI Pharmaceuticals After Q2 Results - ANI Pharmaceuticals (NASDA

ANI Pharmaceuticals Inc (NASDAQ:ANIP) reported strong Q2 earnings, affirmed FY2026 guidance, and saw changes in price targets by analysts.

Raccontata dabenzinga.com